shares of outset medical inc fell 11 to 2531 in early trading after the company reported fourthquarter results that exceeded analyst expectations the medical technology company had a loss of 414 million or 86 cents a share compared with a loss of 412 million or 87 cents a share in the same quarter a year ago stripping out onetime items adjusted loss was 71 cents a share analysts polled by factset had been expecting a bigger loss of 79 cents a share revenue rose 14 to 32 million topping the market consensus for 309 million and its own guidance for 315 million according to factset the company reaffirmed its guidance for 2023 and said revenue might be flat or slightly down sequentially in the first quarter before accelerating through the rest of the year stifel analysts said in a note that the firstquarter outlook makes sense given the exceptionally strong fourth quarter